4.7 Review

Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Sox9/CXCL5 axis facilitates tumour cell growth and invasion in hepatocellular carcinoma

Zhengrong Ren et al.

Summary: This study identifies the Sox9/CXCL5 axis as an endogenous factor in controlling HCC cell growth and invasion, and raises the possibility of pharmacologic intervention with CXCL5/CXCR2 pathway inhibitors in therapy for HCC patients with higher Sox9 expression.

FEBS JOURNAL (2022)

Article Oncology

M1-like tumor-associated macrophages cascade a mesenchymal/stem-like phenotype of oral squamous cell carcinoma via the IL6/Stat3/THBS1 feedback loop

Yuanhe You et al.

Summary: M1-like TAMs induce a mesenchymal/stem-like phenotype in OSCC cells through the IL6/Stat3/THBS1 feedback loop. Further understanding of the functional roles and associated molecular mechanisms of M1-like TAMs may facilitate the development of novel therapies for OSCC patients.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Letter Oncology

HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk

Hengyu Li et al.

Summary: Tumor-associated macrophages (TAMs) promote the activation of hepatic leukemia factor (HLF) in triple-negative breast cancer (TNBC) cells through the secretion of transforming growth factor-beta1 (TGF-beta 1) and subsequently, HLF transactivates gamma-glutamyltransferase 1 (GGT1) to enhance ferroptosis resistance. This process drives TNBC cell proliferation, metastasis, and cisplatin resistance. Additionally, TNBC cells activate the JAK2/STAT3 axis to induce TGF-beta 1 secretion by TAMs, forming a feed-forward circuit. The combination of HLF and GGT1 values can improve the accuracy of TNBC patient prognosis.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

Macrophage-mediated RON signaling supports breast cancer growth and progression through modulation of IL-35

Sasha J. Ruiz-Torres et al.

Summary: The activation of RON signaling in macrophages supports breast cancer growth and metastasis by modulating the interactions with tumor cells and other leukocytes. This involves direct effects on tumor cells and indirect effects by regulating the recruitment of various immune cells in the tumor microenvironment, including macrophages, T-cells, and B-cells. Additionally, macrophage RON expression plays a role in modulating the macrophage secretome, including immunosuppressive factors like IL-35, to promote a pro-tumor environment in breast cancer.

ONCOGENE (2022)

Article Cell Biology

CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression

Meiling Zhang et al.

Summary: Transcriptomic analysis revealed that upregulation of CECR2 is associated with breast cancer metastasis and immune suppression. In mouse models, increased expression of CECR2 promotes breast cancer metastasis. Mechanistically, RELA, a member of the NF-kappa B family, recruits CECR2 to activate the expression of metastasis-related genes.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Cell Biology

Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress

Aushia Tanzih Al Haq et al.

Summary: Triple-negative breast cancer (TNBC) and the aggressive subtypes of HER2(+) breast cancer are associated with high expression levels of mitochondrial superoxide dismutase (MnSOD). The oncoprotein MCT-1 induces MnSOD in TNBC cells by stabilizing the transcription factor Nrf2. High expression of MnSOD correlates with poor prognosis in breast cancer patients.

CELL DEATH & DISEASE (2022)

Article Cell Biology

microRNA-21-5p from M2 macrophage-derived extracellular vesicles promotes the differentiation and activity of pancreatic cancer stem cells by mediating KLF3

Jian Chang et al.

Summary: This research demonstrates that M2 macrophage-derived exosomal miR-21-5p promotes differentiation and activity of PaCa stem cells by targeting KLF3. downregulation of miR-21-5p in M2 macrophage-derived EVs inhibits key cancer stem cell functions in vitro and tumor-forming ability in vivo.

CELL BIOLOGY AND TOXICOLOGY (2022)

Article Immunology

The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33

M. Liguori et al.

Summary: The study reveals a new paracrine axis, GPNMB and IL-33, that is activated during the cross talk between macrophages and tumor cells, eventually promoting cancer cell survival, the expansion of cancer stem cells, and the acquisition of a metastatic phenotype.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Article Cell Biology

Triptolide decreases tumor-associated macrophages infiltration and M2 polarization to remodel colon cancer immune microenvironment via inhibiting tumor-derived CXCL12

Xuan Jiang et al.

Summary: Triptolide treatment shows therapeutic effects against colon cancer both in vivo and in vitro by inhibiting cancer cell proliferation and inducing apoptosis. In the tumor immune microenvironment, triptolide treatment reduces tumor-associated macrophage infiltration by downregulating tumor-derived CXCL12 expression, thus remodeling the immune microenvironment. Triptolide also inhibits the polarization of colon cancer cells to an anti-inflammatory state, and decreases the migration of cancer cells by reducing vascular endothelial growth factor expression.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Pharmacology & Pharmacy

STAT3/NF-κB signalling disruption in M2 tumour-associated macrophages is a major target of PLGA nanocarriers/PD-L1 antibody immunomodulatory therapy in breast cancer

Romulo S. Cavalcante et al.

Summary: The study developed a methotrexate-loaded nanocarrier combined with a PD-L1 antibody to modulate the immune response in breast cancer TME, leading to reduction of primary tumor size and metastases.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

ATXN7L3B promotes hepatocellular carcinoma stemness and is downregulated by metformin

Bi Chen et al.

Summary: The study found that metformin reduces ATXN7L3B levels in HCC cells, decreases ATXN7L3B-induced tumor-initiating ability, and inhibits cancer stemness, supporting the anti-tumor activity and potential of metformin as an anticancer drug for HCC treatment.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Article Oncology

S100 calcium-binding protein A9 from tumor-associated macrophage enhances cancer stem cell-like properties of hepatocellular carcinoma

Ran Wei et al.

Summary: The study revealed that TAMs can enhance the stem cell-like properties of HCC cells by upregulating the secreted protein S100A9, which in turn activates the NF-kB signaling pathway. Additionally, S100A9 can promote the recruitment of macrophages to HCC cells, suggesting a positive feedback loop between TAMs and HCC cells.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Pharmacology & Pharmacy

Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications

Xiaobin Zeng et al.

Summary: Both hereditary and sporadic breast cancer may stem from a subcomponent of stem cells with dysregulated self-renewal pathways. Cancer stem cells play a crucial role in treatment resistance and tumor initiation, highlighting the importance of therapeutic strategies targeting these cells.

PHARMACOLOGICAL RESEARCH (2021)

Review Cell Biology

Cancer Stemness Meets Immunity: From Mechanism to Therapy

Peiwen Chen et al.

Summary: This review explores the symbiotic interactions between cancer stem cells and immune cells, highlighting the importance of tumor-associated macrophages, myeloid-derived suppressor cells, and T cells in maintaining CSC stemness and survival niche. It also discusses therapeutic strategies targeting this co-dependency to disrupt tumor-promoting ecosystems.

CELL REPORTS (2021)

Article Biochemistry & Molecular Biology

Yes associated protein 1 promotes resistance to 5-fluorouracil in gastric cancer by regulating GLUT3-dependent glycometabolism reprogramming of tumor-associated macrophages

Zhanke He et al.

Summary: The overexpression of YAP1 in gastric cancer tissues leads to polarization of macrophages into M2-like phenotype, enhancing resistance of tumor cells to 5-FU.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)

Article Oncology

Extracellular vesicles shed from gastric cancer mediate protumor macrophage differentiation

Atene Ito et al.

Summary: This study found that EVs derived from gastric cancer can affect the phenotypes of macrophages, promoting the malignancy of tumors. This may be a part of the underlying mechanism that forms the intraperitoneal cancer microenvironment.

BMC CANCER (2021)

Article Neurosciences

MFG-E8 attenuates inflammation in subarachnoid hemorrhage by driving microglial M2 polarization

Yong-Yue Gao et al.

Summary: The study found that rhMFG-E8 can inhibit brain edema, improve neurological function, reduce inflammatory factor levels, and promote microglial transformation to the M2 phenotype. However, inhibition of MFG-E8 and integrin beta 3 via specific siRNA, as well as the STAT3 inhibitor Stattic, can abolish the effects of MFG-E8 on anti-inflammation and M2 phenotype polarization.

EXPERIMENTAL NEUROLOGY (2021)

Article Biotechnology & Applied Microbiology

A novel CXCR4 antagonist counteracts paradoxical generation of cisplatin-induced pro-metastatic niches in lung cancer

Giulia Bertolini et al.

Summary: Platinum-based chemotherapy in advanced NSCLC may induce pro-metastatic effects through activation of the CXCR4/SDF-1 axis, which can be prevented by CXCR4 blockade, suggesting a novel combination strategy for controlling metastatic disease.

MOLECULAR THERAPY (2021)

Article Biochemistry & Molecular Biology

Nano formulated Resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages

Rajalaxmi Pradhan et al.

Summary: Tumor associated macrophages in the tumor microenvironment secrete cytokines that regulate cancer cells growth, while Resveratrol nanoparticles reduce the properties of cancer stem like cells. By decreasing cytokine levels, Res-NP inhibits invasion, proliferation, and growth of CSCs in vitro, in vivo, and ex vivo systems.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2021)

Review Cell Biology

Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective

Chiara Donini et al.

Summary: The term cancer stem cells (CSCs) refers to tumor cells with stemness features that may contribute to chemo-resistance and disease relapses, with potential susceptibility to immune system recognition and targeting. Cellular immunotherapies, including those using chimeric antigen receptors (CAR) for genetic redirection, show promise for selective elimination of CSC subsets in different tumor settings. Preclinical studies support the potential targeting of CSCs by cellular immunotherapies, with ongoing clinical studies and new opportunities for T and non-T antitumor lymphocytes.
Article Urology & Nephrology

Identification of prognostic and therapeutic value of CC chemokines in Urothelial bladder cancer: evidence from comprehensive bioinformatic analysis

Yuxin Li et al.

Summary: This study investigated the potential role of CC chemokines as therapeutic targets and prognostic biomarkers in bladder cancer. Differential expression analysis showed that several CC chemokines were significantly downregulated in bladder cancer patients. High expression levels of specific CC chemokines were associated with better prognosis in bladder cancer patients. Additionally, differentially expressed CC chemokines were primarily correlated with cytokine activity, chemokines receptor binding, chemotaxis, and immune cell migration in bladder cancer.

BMC UROLOGY (2021)

Article Biotechnology & Applied Microbiology

M2 macrophage microvesicle-inspired nanovehicles improve accessibility to cancer cells and cancer stem cells in tumors

Yuqi Wang et al.

Summary: The designed M2 macrophage microvesicle-inspired nanovehicle enhances accessibility to cancer cells and CSCs, effectively eliminating CSCs, inhibiting tumor growth, and suppressing lung metastasis. This strategy provides a promising approach for effective cancer therapy.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Article Oncology

FGL2-wired macrophages secrete CXCL7 to regulate the stem-like functionality of glioma cells

Jun Yan et al.

Summary: The study uncovered that in glioma, macrophages promote stem-like phenotypes in cancer cells and immune evasion, showing a close interconnection between the two characteristics in the tumor microenvironment.

CANCER LETTERS (2021)

Article Biochemistry & Molecular Biology

Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion

Ester Gangoso et al.

Summary: In this study, it was found that GBM stem cells acquire the ability to evade immune clearance through epigenetic immunoediting, leading to the formation of an immunosuppressive tumor microenvironment. This process is not driven by genetic selection but by altering the transcriptional and epigenetic profile of GSCs after immune attack.
Review Cell Biology

Potential of E3 Ubiquitin Ligases in Cancer Immunity: Opportunities and Challenges

Peng Ye et al.

Summary: The future of immunotherapy lies in finding new targets and new combination therapy methods to reduce side effects and improve treatment response rate. Ubiquitination plays a crucial role in regulating immune checkpoints and pathways. Drugs targeting E3 ubiquitin ligases have shown beneficial effects in antitumor treatments.
Article Multidisciplinary Sciences

Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation

Heng-Huan Lee et al.

Summary: The study demonstrates that human ribonuclease 1 (hRNase 1) can independently of its ribonucleolytic activity, promoting breast tumor initiation by activating the EphA4 receptor signal and showing a positive correlation with EphA4 activation and the stem cell marker CD133 in tumor tissue. High levels of hRNase 1 in plasma samples are associated with EphA4 activation in breast cancer patients' tumor tissues, suggesting the pathological relevance of the hRNase 1-EphA4 axis in breast cancer.

NATURE COMMUNICATIONS (2021)

Article Oncology

Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer

Xu Cao et al.

Summary: The study found that blocking CD47 and using cabazitaxel can significantly promote the programmed cell removal of TNBC cells, inhibiting tumor development and metastasis, providing a promising new strategy for TNBC treatment.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Oncology

3,3′-Diindolylmethane Promotes Gastric Cancer Progression via β-TrCP-Mediated NF-κB Activation in Gastric Cancer-Derived MSCs

Hui Shi et al.

Summary: The study found that the anti-cancer drug DIM at therapeutic concentrations upregulated the expression of tumor-related factors in GC-MSCs and promoted the proliferation, invasion, and migration of gastric cancer cells, leading to tumor growth. This mechanism provides a new insight into anti-cancer drug resistance and suggests the need to adjust the chemotherapy regimen to minimize the side effects of drugs on targeted TME cells.

FRONTIERS IN ONCOLOGY (2021)

Article Cell Biology

Hematopoietic Cell Kinase (HCK) Is a Player of the Crosstalk Between Hematopoietic Cells and Bone Marrow Niche Through CXCL12/CXCR4 Axis

Fernanda Marconi Roversi et al.

Summary: This study reveals the crucial role of Hematopoietic Cell Kinase (HCK) in the pathogenesis of AML, showing that HCK inhibition severely impairs CXCL12-induced migration of leukemic cell lines and CD34 positive cells from AML patients bone marrow. This suggests that targeting HCK could be a novel approach for AML treatment.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Oncology

Co-culturing polarized M2 Thp-1-derived macrophages enhance stemness of lung adenocarcinoma A549 cells

Xiaocheng Zhang et al.

Summary: The study found that THP-1-derived macrophages can enhance the proliferation and stemness of A549 cells through multiple pro-tumorigenic pathways. Inhibitors were able to reduce the proliferation and stemness of the co-culture system, as well as decrease the expression of related mRNA and proteins.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Article Immunology

Tumor-associated macrophages-mediated CXCL8 infiltration enhances breast cancer metastasis: Suppression by Danirixin

Gang Nie et al.

Summary: Breast cancer stem cells and tumor-associated macrophages play crucial roles in breast cancer growth and metastasis. High CXCL8 expression is significantly associated with metastasis and tumor growth in breast cancer patients. Danirixin effectively reduces tumor growth, metastasis, and suppresses self-renewal of stem cells.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Article Oncology

M2-like tumour-associated macrophage-secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K/AKT/mTOR pathway

Juan Lv et al.

Summary: The study revealed that M2-like tumour-associated macrophages (TAMs) can accelerate metastasis and increase stemness of anaplastic thyroid carcinoma (ATC) cells, potentially through the secretion of IGF that activates the IR-A/IGF1R-mediated PI3K/AKT/mTOR signalling pathway.

MOLECULAR MEDICINE REPORTS (2021)

Article Biochemistry & Molecular Biology

β-Catenin-CCL2 feedback loop mediates crosstalk between cancer cells and macrophages that regulates breast cancer stem cells

Fan Zhang et al.

Summary: Breast cancer is the most common cancer among women worldwide, and while advancements have improved survival rates, metastasis remains a major obstacle. Breast cancer stem cells play a key role in metastasis and recurrence. Targeting the beta-Catenin/CCL2 signaling pathway may be an effective strategy for breast cancer therapy, as shown in this study's findings.

ONCOGENE (2021)

Article Biotechnology & Applied Microbiology

Synergy of nanodiamond-doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells

Hua-Zhen Xu et al.

Summary: The combination of Nano-DOX and BMS-1 can activate TAMs' M1-type response, inhibit tumor cell growth, and achieve synergistic therapeutic efficacy against tumors.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Article Immunology

Fusobacterium nucleatum Facilitates M2 Macrophage Polarization and Colorectal Carcinoma Progression by Activating TLR4/NF-κB/S100A9 Cascade

Lijun Hu et al.

Summary: The research found that Fusobacterium nucleatum infection is closely associated with the development of colorectal cancer, primarily by promoting the polarization of M2 macrophages to exacerbate tumor malignancy. S100A9 is a key signaling molecule that regulates the activation of M2 macrophages. Targeting the TLR4/NF-kappa B/S100A9 cascade may serve as a promising therapeutic strategy for Fusobacterium nucleatum-associated colorectal cancer.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

CC Chemokine Ligand 7 Derived from Cancer-Stimulated Macrophages Promotes Ovarian Cancer Cell Invasion

Miran Jeong et al.

Summary: This study highlights the interaction between macrophages and ovarian cancer cells in metastasis. CCL7 in macrophages promotes ovarian cancer cell invasion, contributing to the development and metastasis of ovarian cancer. The CCL7/CCR3 axis may play a crucial role in the effect of tumor-associated macrophages on human ovarian cancer metastasis.

CANCERS (2021)

Review Oncology

A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead

Mahdi Abdoli Shadbad et al.

Summary: CD44 and CD44(+)CD24(-/low) phenotype are associated with poor prognosis in TNBC patients, and these cancer stem cell markers are linked to advanced tumor stage, size, grade, metastasis, and lymphatic involvement in TNBC patients. Additionally, chemoradiotherapy-treated TNBC patients show an upregulation of CD44(+)CD24(-/low) phenotype, which inversely correlates with androgen receptor (AR) and leads to inferior prognosis.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Blocking the CCL5-CCR5 Axis Using Maraviroc Promotes M1 Polarization of Macrophages Cocultured with Irradiated Hepatoma Cells

Yuan Zhuang et al.

Summary: The study showed that the CCR5 antagonist MVC can induce macrophage polarization towards the M1 phenotype by blocking the CCL5-CCR5 signaling pathway, thereby enhancing the sensitivity and apoptosis of human hepatoma cells to radiation.

JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)

Review Biochemistry & Molecular Biology

Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents

He-Ming Zhou et al.

Summary: Understanding the key characteristics and resistance mechanisms of CSCs may improve patient outcomes and reduce relapse. Targeting the mechanisms and pathways of CSCs described in this review could lead to further drug discovery and therapy development.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Medicine, Research & Experimental

CCL8 secreted by tumor-associated macrophages promotes invasion and stemness of glioblastoma cells via ERK1/2 signaling

Xiang Zhang et al.

LABORATORY INVESTIGATION (2020)

Review Biochemistry & Molecular Biology

Toll-like Receptors and the Control of Immunity

Katherine A. Fitzgerald et al.

Review Cell Biology

CCL2/CCR2 signaling in cancer pathogenesis

Qiongyu Hao et al.

CELL COMMUNICATION AND SIGNALING (2020)

Review Chemistry, Medicinal

Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview

Subha Mondal et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Oncology

The role of cancer stem cells in immunotherapy for bladder cancer: An in vitro study

Yegane Ozcan et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)

Review Pharmacology & Pharmacy

Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma

Helene Gregoire et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Immunology

Nucleic Acid Sensors as Therapeutic Targets for Human Disease

Sarah M. McWhirter et al.

IMMUNITY (2020)

Article Biochemistry & Molecular Biology

CCR5-Mediated Signaling is Involved in Invasion of Glioblastoma Cells in Its Microenvironment

Metka Novak et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Medicine, Research & Experimental

Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer

Jason R. Brown et al.

JCI INSIGHT (2020)

Review Oncology

EZH2-Targeted Therapies in Cancer: Hype or a Reality

Marie-Lisa Eich et al.

CANCER RESEARCH (2020)

Article Multidisciplinary Sciences

Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma

Weiwei Tao et al.

NATURE COMMUNICATIONS (2020)

Review Biochemistry & Molecular Biology

CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands

Jan Korbecki et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Immunology

Tumor-Associated Macrophages in Tumor Immunity

Yueyun Pan et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Cell Biology

EZH2-Inhibited MicroRNA-454-3p Promotes M2 Macrophage Polarization in Glioma

Bin Qi et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Review Biochemistry & Molecular Biology

Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment

Kayla V. Myers et al.

MOLECULAR CANCER (2019)

Review Immunology

Targeting Tumor-Associated Macrophages in Cancer

Paulina Pathria et al.

TRENDS IN IMMUNOLOGY (2019)

Review Oncology

The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis

Zhenpeng Wang et al.

FRONTIERS IN ONCOLOGY (2019)

Article Oncology

The role of TNF-α in chordoma progression and inflammatory pathways

Sukru Gulluoglu et al.

CELLULAR ONCOLOGY (2019)

Review Cell Biology

Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities

Florian Rambow et al.

GENES & DEVELOPMENT (2019)

Review Biotechnology & Applied Microbiology

Pharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles

Claire Vanpouille-Box et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Article Cell Biology

Ocoxin Modulates Cancer Stem Cells and M2 Macrophage Polarization in Glioblastoma

Esther Hernandez-SanMiguel et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)

Review Medical Laboratory Technology

Biochemical diagnostics of pancreatic cancer - Present and future

Wojciech Jelski et al.

CLINICA CHIMICA ACTA (2019)

Article Biochemistry & Molecular Biology

Low-dose photodynamic therapy promotes angiogenic potential and increases immunogenicity of human mesenchymal stromal cells

Olga O. Udartsevaa et al.

JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2019)

Review Immunology

Macrophages as regulators of tumour immunity and immunotherapy

David G. DeNardo et al.

NATURE REVIEWS IMMUNOLOGY (2019)

Review Oncology

Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme

Miha Koprivnikar Kranjc et al.

RADIOLOGY AND ONCOLOGY (2019)

Article Medicine, Research & Experimental

Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8/STAT3 signaling

Yingxia Ning et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Editorial Material Immunology

Repressing the repressor: Ezh2 mediates macrophage activation

Annette E. Neele et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Article Pharmacology & Pharmacy

Imatinib prevents lung cancer metastasis by inhibiting M2-like polarization of macrophages

Zhangting Yao et al.

PHARMACOLOGICAL RESEARCH (2018)

Review Oncology

Targeting Macrophages in Cancer: From Bench to Bedside

Ashleigh R. Poh et al.

FRONTIERS IN ONCOLOGY (2018)

Article Biochemistry & Molecular Biology

Elevated IL-33 promotes expression of MMP2 and MMP9 via activating STAT3 in alveolar macrophages during LPS-induced acute lung injury

Yafeng Liang et al.

CELLULAR & MOLECULAR BIOLOGY LETTERS (2018)

Article Multidisciplinary Sciences

Integrin CD11b activation drives anti-tumor innate immunity

Michael C. Schmid et al.

NATURE COMMUNICATIONS (2018)

Article Cell & Tissue Engineering

Tropism of mesenchymal stem cell toward CD133(+) stem cell of glioblastoma in vitro and promote tumor proliferation in vivo

Lorena Favaro Pavon et al.

STEM CELL RESEARCH & THERAPY (2018)

Article Medicine, Research & Experimental

Molecular mechanisms of IL-33-mediated stromal interactions in cancer metastasis

Patrik Andersson et al.

JCI INSIGHT (2018)

Review Immunology

Tumor-Associated Macrophages as Target for Antitumor Therapy

Katarzyna Sawa-Wejksza et al.

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2018)

Review Chemistry, Medicinal

An update on small molecules targeting CXCR4 as starting points for the development of anti-cancer therapeutics

Fedora Grande et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Review Biochemistry & Molecular Biology

Drug Resistance Driven by Cancer Stem Cells and Their Niche

Marta Prieto-Vila et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Gastroenterology & Hepatology

Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages

Chiara Raggi et al.

JOURNAL OF HEPATOLOGY (2017)

Article Pharmacology & Pharmacy

Danirixin: A Reversible and Selective Antagonist of the CXC Chemokine Receptor 2

Jakob Busch-Petersen et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)

Article Multidisciplinary Sciences

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages

Jennifer L. Guerriero et al.

NATURE (2017)

Review Oncology

Tumour-associated macrophages as treatment targets in oncology

Alberto Mantovani et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Review Oncology

The challenge of targeting cancer stem cells to halt metastasis

Alice Agliano et al.

SEMINARS IN CANCER BIOLOGY (2017)

Article Oncology

Crosstalk between M2 macrophages and glioma stem cells

Leora M. Nusblat et al.

CELLULAR ONCOLOGY (2017)

Review Pharmacology & Pharmacy

Exosome-Based Cancer Therapy: Implication for Targeting Cancer Stem Cells

Jinheng Wang et al.

FRONTIERS IN PHARMACOLOGY (2017)

Review Oncology

Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy

Michael A. Cannarile et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)

Article Biochemistry & Molecular Biology

Myc Cooperates with Ras by Programming Inflammation and Immune Suppression

Roderik M. Kortlever et al.

Article Nanoscience & Nanotechnology

Exploration of Zinc Oxide Nanoparticles as a Multitarget and Multifunctional Anticancer Nanomedicine

Jiao Wang et al.

ACS APPLIED MATERIALS & INTERFACES (2017)

Review Oncology

Targeting EZH2 in cancer therapy

Makoto Yamagishi et al.

CURRENT OPINION IN ONCOLOGY (2017)

Article Cell Biology

Culture supernatants of cervical cancer cells induce an M2 phenotypic profile in THP-1 macrophages

Eliza Julia Pedraza-Brindis et al.

CELLULAR IMMUNOLOGY (2016)

Article Clinical Neurology

Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling

Omar Dildar A. Dzaye et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2016)

Article Multidisciplinary Sciences

PI3Kγ is a molecular switch that controls immune suppression

Megan M. Kaneda et al.

NATURE (2016)

Review Gastroenterology & Hepatology

Pancreatic cancer stem cell markers and exosomes - the incentive push

Sarah Heiler et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Article Oncology

Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression

Megan M. Kaneda et al.

CANCER DISCOVERY (2016)

Review Oncology

Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2

Anthos Christofides et al.

ONCOTARGET (2016)

Article Oncology

CXCR4 antagonists suppress small cell lung cancer progression

Sanaz Taromi et al.

ONCOTARGET (2016)

Article Oncology

Targeting the CCL2-CCR2 signaling axis in cancer metastasis

Su Yin Lim et al.

ONCOTARGET (2016)

Article Oncology

Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms

Michele Cioffi et al.

CLINICAL CANCER RESEARCH (2015)

Article Medicine, Research & Experimental

Ovarian cancer stem cells induce the M2 polarization of macrophages through the PPARγ and NF-κB pathways

Xinchao Deng et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)

Article Biochemistry & Molecular Biology

Exposure of Tumor-Associated Macrophages to Apoptotic MCF-7 Cells Promotes Breast Cancer Growth and Metastasis

Na Zhou et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)

Article Gastroenterology & Hepatology

Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma

Oscar W. H. Yeung et al.

JOURNAL OF HEPATOLOGY (2015)

Article Oncology

Ovarian cancer stem-like cells elicit the polarization of M2 macrophages

Qing Zhang et al.

MOLECULAR MEDICINE REPORTS (2015)

Article Multidisciplinary Sciences

CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer

Ming T. Cheah et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Multidisciplinary Sciences

HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells

Huimin Zhang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Gastroenterology & Hepatology

Alcohol, TLR4-TGF-β antagonism, and liver cancer

Hidekazu Tsukamoto et al.

HEPATOLOGY INTERNATIONAL (2014)

Article Oncology

Involvement of CXCL14 in osteolytic bone metastasis from lung cancer

Soichi Takiguchi et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2014)

Article Cell Biology

Cytokines driving breast cancer stemness

Andrew R. Chin et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)

Review Oncology

Role of macrophage inflammatory protein (MIP)-1α/CCL3 in leukemogenesis

Tomohisa Baba et al.

MOLECULAR & CELLULAR ONCOLOGY (2014)

Editorial Material Pharmacology & Pharmacy

Targeting IL-8 signalling to inhibit breast cancer stem cell activity

Jagdeep K. Singh et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2013)

Article Biochemistry & Molecular Biology

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

Stephanie M. Pyonteck et al.

NATURE MEDICINE (2013)

Review Biochemistry & Molecular Biology

Macrophage-tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands

Thomas Schmidt et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2012)

Article Medicine, General & Internal

Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma

Aleksandar Sekulic et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Multidisciplinary Sciences

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Stephen B. Willingham et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Cell & Tissue Engineering

Monoclonal Antibodies Against Lgr5 Identify Human Colorectal Cancer Stem Cells

Kristel Kemper et al.

STEM CELLS (2012)

Article Multidisciplinary Sciences

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

Bin-Zhi Qian et al.

NATURE (2011)

Article Multidisciplinary Sciences

Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells

Masahisa Jinushi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Biochemistry & Molecular Biology

CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis

Jian Zhang et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2010)

Article Multidisciplinary Sciences

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

Keith Syson Chan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Multidisciplinary Sciences

STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling

Hiroki Ishikawa et al.

NATURE (2008)